Previous 10 | Next 10 |
GVOKE Pre-Filled Syringe (PFS) is available for home delivery through PillPack by Amazon Pharmacy Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable an...
Image source: The Motley Fool. Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) Q4 2019 Earnings Call Mar 11, 2020 , 8:30 a.m. ET Operator Continue reading
Xeris Pharmaceuticals, Inc. (XERS) Q4 2019 Results Earnings Conference Call March 11, 2020, 08:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communications Paul Edick - Chairman & Chief Executive Officer Barry Deutsch - ...
Xeris Pharmaceuticals (NASDAQ: XERS ): Q4 GAAP EPS of -$1.23 misses by $0.08 . Revenue of $1.63M beats by $0.97M . Shares +4% PM. Press Release More news on: Xeris Pharmaceuticals, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,
GVOKE™ PFS net sales of $1.6 million in Q4 2019 GVOKE HypoPen™ on track for planned launch in July 2020 All current clinical programs expected to report topline results in 1H 2020 Conference call and webcast today at 8:30 a.m. ET Xeris Pharmaceuticals, In...
CHICAGO, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Comp...
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that, in connection with its previously announced underwritten public ...
Viveve Medical (NASDAQ: VIVE ) +35% . More news on: Viveve Medical, Inc., Quad/Graphics, Inc., Myomo, Inc., Stocks on the move, Read more ...
Zosano Pharma (NASDAQ: ZSAN ) -47% after pricing stock offering. More news on: Zosano Pharma Corporation, PolarityTE, Inc., PDS Biotechnology Corporation, Stocks on the move, , Read more ...
Xeris Pharmaceuticals (NASDAQ: XERS ) has priced a 9M-share public offering at $4.15 each. More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
Xeris Pharmaceuticals Inc. Website:
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will pres...
Achieved Total Revenue of over $44M in the fourth quarter – a 34% increase from same period prior year and generated approximately $164M for the full year 2023, a 49% increase versus prior year Ended 2023 with over $72M in cash, cash equivalents, and short-term investments achievin...